carvedilol has been researched along with Systemic Vasculitis in 1 studies
Systemic Vasculitis: A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol treatment fully prevented damage to the heart and kidney and attenuated liver lesions induced by the Ang II infusion." | 1.36 | Protective effects of carvedilol on systemic vascular damage induced by angiotensin II: organ-specific effects independent of antihypertensive effects. ( Matsubara, BB; Matsubara, LS; Padovani, CR; Rocha, NS; Schwartz, DS; Vailati, Mdo C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vailati, Mdo C | 1 |
| Rocha, NS | 1 |
| Matsubara, LS | 1 |
| Padovani, CR | 1 |
| Schwartz, DS | 1 |
| Matsubara, BB | 1 |
1 other study available for carvedilol and Systemic Vasculitis
| Article | Year |
|---|---|
Protective effects of carvedilol on systemic vascular damage induced by angiotensin II: organ-specific effects independent of antihypertensive effects.
Topics: Analysis of Variance; Angiotensin II; Animals; Carbazoles; Carvedilol; Heart; Histocytochemistry; Ki | 2010 |